MRC1 and central nervous system neoplasm: Together, these extrapolated statistics suggest that MMR deficiency testing of Lynch-spectrum tumours, excepting CNS tumours and SNs, to screen for LS would have equivalent accuracy to MMR deficiency testing of CRCs and ECs.